We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Book and Media Reviews |


Griffin Trotter, MD, PhD, Reviewer
JAMA. 2008;300(6):733-734. doi:10.1001/jama.300.6.733.
Text Size: A A A
Published online


In Bioviolence, Barry Kellman defines bioviolence as “the infliction of harm by the intentional manipulation of living micro-organisms or their natural products for hostile purposes” (p 1). Kellman argues that bioviolence is a serious threat, that “wise strategies” exist to effectively reduce this threat, and that important changes in global governance are required to enact such wise strategies.

The first section (chapters 1-3) outlines the threat. Chapter 2, which covers methods of bioviolence, will be of interest to clinicians for its comprehensiveness. However, it is not detailed enough to serve as a clinical reference. The strength of the section is chapter 3, in which the author provides a succinct and informative overview of past and potential bioviolence perpetrators. Much of the information here will be new even for readers who have read widely in the field. For instance, Kellman discusses Egypt's 1960s bioweapons program and updates the reader on unclassified information pertaining to the attempts of Al Qaeda to secure biological weapons.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.